Publications by authors named "Jay Hsu"

Claim this Profile
S
Short-term Efficacy and Safety of Lurasidone Versus Placebo in Antipsychotic-Naïve vs. Previously Treated Adolescents with an Acute Exacerbation of Schizophrenia.
Christoph U Correll, Michael Tocco, Jay Hsu, Robert Goldman, Andrei Pikalov

Eur Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis.
Christoph U Correll, Michael Tocco, Andrei Pikalov, Jay Hsu, Robert Goldman

Schizophr Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study.
Preeya J Patel, Christian Weidenfeller, Andrew P Jones, Jens Nilsson, Jay Hsu

Neurol Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial.
Lenard A Adler, Robert Goldman, Seth C Hopkins, Kenneth S Koblan, Justine Kent, Jay Hsu

Int Clin Psychopharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies.
Isabella Costamagna, Fabrizio Calisti, Agnese Cattaneo, Jay Hsu, Michael Tocco

Eur Psychiatry· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study.
Sharon B Wigal, Seth C Hopkins, Kenneth S Koblan, Ann Childress, Justine M Kent, Jay Hsu

J Atten Disord· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial.
Robert L Findling, Lenard A Adler, Thomas J Spencer, Robert Goldman, Seth C Hopkins, Jay Hsu

J Child Adolesc Psychopharmacol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of lurasidone in the treatment of agitation: A post hoc analysis of five short-term studies in acutely ill patients with schizophrenia.
Michael H Allen, Leslie Citrome, Andrei Pikalov, Jay Hsu, Antony Loebel

Gen Hosp Psychiatry· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study.
Christoph U Correll, Josephine Cucchiaro, Robert Silva, Jay Hsu, Andrei Pikalov

CNS Spectr· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.
George Awad, Daisy Ng-Mak, Krithika Rajagopalan, Jay Hsu, Andrei Pikalov

BMC Psychiatry· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.
Sunny Chapel, Yu-Yuan Chiu, Jay Hsu, Josephine Cucchiaro, Antony Loebel

Clin Ther· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of lurasidone for bipolar depression.
Antony Loebel, Jane Xu, Jay Hsu, Josephine Cucchiaro, Andrei Pikalov

Ann N Y Acad Sci· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study.
Leslie Citrome, Peter J Weiden, Joseph P McEvoy, Christoph U Correll, Josephine Cucchiaro, Jay Hsu

CNS Spectr· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
Antony Loebel, Josephine Cucchiaro, Robert Silva, Hans Kroger, Jay Hsu

Am J Psychiatry· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.
George Awad, Mariam Hassan, Antony Loebel, Jay Hsu, Andrei Pikalov

BMC Psychiatry· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of lurasidone on neurocognitive performance in patients with schizophrenia: a short-term placebo- and active-controlled study followed by a 6-month double-blind extension.
Philip D Harvey, Cynthia O Siu, Jay Hsu, Josephine Cucchiaro, Paul Maruff

Eur Neuropsychopharmacol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.
Henry A Nasrallah, Robert Silva, Debra Phillips, Josephine Cucchiaro, Jay Hsu

J Psychiatr Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study.
Stephen M Stahl, Josephine Cucchiaro, Doreen Simonelli, Jay Hsu, Andrei Pikalov

J Clin Psychiatry· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.
Joseph P McEvoy, Leslie Citrome, David Hernandez, Josephine Cucchiaro, Jay Hsu

J Clin Psychiatry· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local disruption of the celiac ganglion inhibits substance P release and ameliorates caerulein-induced pancreatitis in rats.
Marc D Noble, Joelle Romac, Yu Wang, Jay Hsu, John E Humphrey

Am J Physiol Gastrointest Liver Physiol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis